A Better Looking Bottom for Coal Stocks With the Help of George Soros

Coal is a dying source of energy. It has left a trail of tears in the stock market. Communities reliant on coal have been long-suffering. So I was quite surprised to read that George Soros bought back into coal stocks from April to June, 2015. This is the same man who once called coal a … Read more

Fed’s Insistence On Transitory Disinflation Puts A Pause on the GLD Trade

(This is an excerpt from an article I originally published on Seeking Alpha on January 29, 2015. Click here to read the entire piece.) This year has started for SPDR Gold Shares (GLD) in a fashion eerily similar to 2014. On December 18, 2013, the Federal Reserve officially announced the planned tapering of its bond … Read more

Shopping for Lessons With Zulily

I thought I was done blogging about Zulily (ZU). The acquisition of ZU by Liberty Interactive (QVCA) on August 17, 2015 brought back the pain that was ZU right back into full view for me. My mistake with ZU started a little over a year ago as a play on a relatively consistent stock market … Read more

When Your Best Is Not Good Enough: The James Harrison School of Investing

https://instagram.com/p/6aXCJ2JFi5/ I heard about this Instagram post on CNBC of all places. The article was brief and just reported the news. I was expecting some commentary directly linking this to financial markets. Seeing none, I will make my own link here. James Harrison is a linebacker in America’s National Football League. He plays for a … Read more

Intercept Pharmaceuticals Loses More Momentum As Morgan Stanley Weighs

Morgan Stanley (MS) initiated coverage on Intercept Pharmaceuticals, Inc. (ICPT) with an underweight rating. The negativity weighed on the stock for a 7.9% loss that sent the stock below critical support at its 200-day moving average (DMA). Source: FreeStockCharts.com Morgan was VERY emphatic about its “out of consensus” call on ICPT. As reported by Investors.com: … Read more